Literature DB >> 10707927

Beta1 integrins play an essential role in adhesion and invasion of pancreatic carcinoma cells.

S Arao1, A Masumoto, M Otsuki.   

Abstract

To investigate the role of beta1 integrins in pancreatic carcinoma invasion, we analyzed the relationship between the activity of beta1 integrins and the invasive ability of human pancreatic carcinoma cell lines. AsPC1, BxPC3, PANC1, SU8686, KP1NL, KP2, and H48N cells had high expression of beta1 and alpha6 subunits, and various levels of alpha2, alpha3, and alpha5 expression as determined by flow cytometry. Cell adhesion assay revealed that alpha2beta1, alpha5beta1, and alpha6beta1 integrins were the predominant adhesion receptors for collagen, fibronectin, and laminin, respectively. Beta1 integrins on different cell types showed a wide range of constitutive activity. Anti-beta1 monoclonal antibody (MAB) TS2/16 rapidly activated beta1 integrins, and thus TS2/16 requirement in cell adhesion represented the levels of constitutive activity of beta1 integrins. Notably, as the result of in vitro chemoinvasion assay, the levels of constitutive activity of beta1 integrins correlated with the invasive ability of pancreatic carcinoma cells. The inhibitory anti-beta1 MAB 13 completely blocked the invasion of these cell lines. Alternatively, the stimulatory anti-beta1 MAB TS2/16 strongly inhibited the invasion. These results show an essential role of beta1 integrins in invasion of pancreatic carcinoma cells and also suggest subtle regulatory mechanisms of cell invasion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10707927     DOI: 10.1097/00006676-200003000-00004

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  20 in total

Review 1.  Role of cell adhesion molecules in leukocyte recruitment in the liver and gut.

Authors:  A Ala; A P Dhillon; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2003-02       Impact factor: 1.925

Review 2.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.

Authors:  Pinar Kanlikilicer; Mohammed H Rashed; Recep Bayraktar; Rahul Mitra; Cristina Ivan; Burcu Aslan; Xinna Zhang; Justyna Filant; Andreia M Silva; Cristian Rodriguez-Aguayo; Emine Bayraktar; Martin Pichler; Bulent Ozpolat; George A Calin; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Cancer Res       Date:  2016-10-14       Impact factor: 12.701

4.  Integrin β1 regulates leiomyoma cytoskeletal integrity and growth.

Authors:  Minnie Malik; James Segars; William H Catherino
Journal:  Matrix Biol       Date:  2012-09-26       Impact factor: 11.583

5.  β1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway.

Authors:  Jia Song; Jixiang Zhang; Jing Wang; Jun Wang; Xufeng Guo; Weiguo Dong
Journal:  Tumour Biol       Date:  2014-11-12

6.  Expression and prognostic roles of integrins and interleukin-1 receptor type I in patients with ductal adenocarcinoma of the pancreas.

Authors:  Hirozumi Sawai; Hitoshi Funahashi; Yoichi Matsuo; Minoru Yamamoto; Yuji Okada; Tetsushi Hayakawa; Tadao Manabe
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 7.  The tumor microenvironment and metastatic disease.

Authors:  Sarah Jane Lunt; Naz Chaudary; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2008-06-10       Impact factor: 5.150

Review 8.  Glucose metabolic phenotype of pancreatic cancer.

Authors:  Anthony K C Chan; Jason I E Bruce; Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

9.  A new liver metastatic and peritoneal dissemination model established from the same human pancreatic cancer cell line: analysis using cDNA macroarray.

Authors:  Hiroki Nomura; Hidefumi Nishimori; Takahiro Yasoshima; Fumitake Hata; Hiroshi Tanaka; Futoshi Nakajima; Toshio Honma; Jun Araya; Kenjiro Kamiguchi; Hiroshi Isomura; Noriyuki Sato; Ryuichi Denno; Koichi Hirata
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Authors:  Lirong Peng; Xiaofang Xing; Weijun Li; Like Qu; Lin Meng; Shenyi Lian; Beihai Jiang; Jian Wu; Chengchao Shou
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.